ATE198603T1 - Bivalente thrombininhibitore - Google Patents

Bivalente thrombininhibitore

Info

Publication number
ATE198603T1
ATE198603T1 AT94930133T AT94930133T ATE198603T1 AT E198603 T1 ATE198603 T1 AT E198603T1 AT 94930133 T AT94930133 T AT 94930133T AT 94930133 T AT94930133 T AT 94930133T AT E198603 T1 ATE198603 T1 AT E198603T1
Authority
AT
Austria
Prior art keywords
thrombin
glu
pct
inhibitors
active site
Prior art date
Application number
AT94930133T
Other languages
English (en)
Inventor
Yasuo Konishi
Zbigniew Szewczuk
Yuko Tsuda
Original Assignee
Ca Nat Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9321951A external-priority patent/GB9321951D0/en
Application filed by Ca Nat Research Council filed Critical Ca Nat Research Council
Application granted granted Critical
Publication of ATE198603T1 publication Critical patent/ATE198603T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/815Protease inhibitors from leeches, e.g. hirudin, eglin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT94930133T 1993-10-25 1994-10-25 Bivalente thrombininhibitore ATE198603T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9321951A GB9321951D0 (de) 1993-10-25 1993-10-25
GB9412707A GB9412707D0 (de) 1993-10-25 1994-06-24
PCT/CA1994/000585 WO1995011921A1 (en) 1993-10-25 1994-10-25 Bivalent thrombin inhibitors

Publications (1)

Publication Number Publication Date
ATE198603T1 true ATE198603T1 (de) 2001-01-15

Family

ID=26303742

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94930133T ATE198603T1 (de) 1993-10-25 1994-10-25 Bivalente thrombininhibitore

Country Status (8)

Country Link
US (1) US6127337A (de)
EP (1) EP0725797B1 (de)
AT (1) ATE198603T1 (de)
AU (1) AU7935494A (de)
CA (1) CA2175388A1 (de)
DE (1) DE69426569T2 (de)
ES (1) ES2153433T3 (de)
WO (1) WO1995011921A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001519442A (ja) * 1997-10-15 2001-10-23 ナショナル・リサーチ・カウンシル・オブ・カナダ 三価のトロンビン阻害剤
US7829085B2 (en) 1999-07-14 2010-11-09 Life Sciences Research Partners Vzw Methods of treating hemostasis disorders using antibodies binding the C1 domain of factor VIII
EP1278549B1 (de) 2000-05-02 2008-12-10 Theravance, Inc. Zusammensetzung die eine zyklodextrin und ein glykopeptid-antibiotikum enthält
JP4934796B2 (ja) * 2003-08-14 2012-05-16 トロンボジェニクス・ナムローゼ・フエンノートシャップ 可変抗体
WO2006000081A1 (en) * 2004-06-23 2006-01-05 National Research Council Of Canada Polypeptide ligands containing linkers
US7915223B2 (en) * 2004-09-27 2011-03-29 Technion Research & Development Foundation Ltd. Antimicrobial agents
WO2006035431A2 (en) * 2004-09-27 2006-04-06 Technion Research & Development Foundation Ltd. Fatty acid modified polylysines as antimicrobial agents
CN101094867B (zh) 2004-10-19 2011-08-24 隆萨股份公司 用于固相肽合成的方法
WO2008077621A1 (de) * 2006-12-23 2008-07-03 Aplagen Gmbh Verfahren zur ausbildung von disulfidbrücken
US20080269065A1 (en) * 2007-04-30 2008-10-30 Syntrix Biosystems, Inc. Conformationally Constrained Analytical Probes
US20100173832A1 (en) * 2007-04-30 2010-07-08 Technion Research & Development Foundation Ltd. Anticancerous polymeric agents
WO2008132737A1 (en) * 2007-04-30 2008-11-06 Technion Research & Development Foundation Ltd. Novel antimicrobial agents
GB0711779D0 (en) 2007-06-18 2007-07-25 Univ Singapore Thrombin inhibitor
EP2346526A2 (de) 2008-09-22 2011-07-27 Massachusetts Institute of Technology Zusammensetzungen und verfahren zur verwendung von liganden-dimeren
US9029328B2 (en) 2010-03-24 2015-05-12 The Brigham And Women's Hospital, Inc. Methods for cardioprotection and cardioregeneration with dimers of EGF family ligands

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3978045A (en) * 1973-08-13 1976-08-31 Mitsubishi Chemical Industries Ltd. N2 -dansyl-L-arginine derivatives, and the pharmaceutically acceptable acid addition salts thereof
US4173630A (en) * 1974-11-08 1979-11-06 Mitsubishi Chemical Industries Limited N2 Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US5196404B1 (en) * 1989-08-18 1996-09-10 Biogen Inc Inhibitors of thrombin
JP2669510B2 (ja) * 1990-06-15 1997-10-29 ナショナル・リサーチ・カウンシル・オブ カナダ ヒルジンのアミノ酸配列に基づくトロンビン阻害剤
GB9209032D0 (en) * 1992-04-25 1992-06-10 Ciba Geigy Ag New peptide derivatives

Also Published As

Publication number Publication date
DE69426569D1 (de) 2001-02-15
EP0725797A1 (de) 1996-08-14
ES2153433T3 (es) 2001-03-01
CA2175388A1 (en) 1995-05-04
WO1995011921A1 (en) 1995-05-04
US6127337A (en) 2000-10-03
DE69426569T2 (de) 2001-05-10
AU7935494A (en) 1995-05-22
EP0725797B1 (de) 2001-01-10

Similar Documents

Publication Publication Date Title
ES2153433T3 (es) Inhibidores de trombina bivalentes.
ES8601858A1 (es) Homologos de la aprotinina
IL118158A0 (en) IL-6 activity inhibitor
ATE184022T1 (de) Neuropeptide y antagoniste
IL109016A (en) Purified soluble vascular endothelial cell growth factor (vegf) inhibitor encoding purified dna, a process for its preparation and pharmaceutical compositions comprising it
FI962591A0 (fi) Kasvuhormonia vapauttavia ominaisuuksia sisältäviä yhdisteitä
WO2001005810A3 (de) CYCLISCHE PEPTIDDERIVATE ALS INHIBITOREN DES INTEGRINS αvβ¿6?
DE69434070D1 (de) Kininogen-inhibitoren
DE60228878D1 (de) Proteine mit il-6 inhibitorischer wirkung
DK0688226T3 (da) Proteinpræparat til forebyggelse og terapi af periodontitis eller andre bakterielle patologier i mundhulen
FI956055A0 (fi) Tekijä VII:sta johdettuja peptidejä
ATE208793T1 (de) Thrombin-inhibitoren
IL148173A0 (en) Peptide analogs as selective inhibitors of thrombin activation of protease activated receptor 1
RU97112745A (ru) Варианты апротинина с улучшенными свойствами
TW340849B (en) Novel cyclopeptides and pharmaceutical compositions as integrin inhibitors comprizing the same
DE69615185D1 (de) Faktor ix bindende peptide abgeleitet von faktor vii und ihre verwendung als inhibitoren der blutgerinnung
ATE146526T1 (de) Neues thrombininhibitorisches protein aus zecken
SE9901773D0 (sv) Förebyggande av karies i tänderna
NO924925D0 (no) Bradykinin-antagonister for behandling av akutt betennelse i bukspyttkjertelen
MX9605037A (es) Inhibidores de factor xa.
GR850626B (de)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee